
Olwohn AT 40mg/5mg/12.5mg Tablet
Marketer
Riyadh Pharmaceutical
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olwohn AT 40mg/5mg/12.5mg Tablet
Hypertan 40mg/5mg/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Hypertan 40mg/5mg/12.5mg tablets may be taken with or without food, with dosage tailored to individual response and condition. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial. The diuretic component increases urination; therefore, avoid late-evening administration (within four hours of bedtime). Regular use maximizes therapeutic benefit, even during asymptomatic periods, as hypertension often presents subtly. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects include edema (ankle swelling), cephalgia (headache), vertigo (dizziness), fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential dryness, thirst, and muscle weakness. Prior to commencing treatment, inform your doctor about any renal or hepatic impairment. Pregnant or lactating individuals should seek medical counsel. Disclosure of all current medications, particularly those addressing hypertension or cardiac issues, is essential. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia ensures optimal therapeutic efficacy.
Uses of Olwohn AT 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Olwohn AT 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olwohn AT 40mg/5mg/12.5mg Tablets can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Olwohn AT 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olwohn AT 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olwohn AT 40mg/5mg/12.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Olwohn AT 40mg/5mg/12.5mg Tablet works:
Olmesartan medoxomil, amlodipine, and hydrochlorothiazide—a triple-drug formulation marketed as Olwohn AT 40mg/5mg/12.5mg—provides comprehensive blood pressure management. The ARB, olmesartan medoxomil, and the CCB, amlodipine, act synergistically to vasodilate, reducing blood pressure. Hydrochlorothiazide, a diuretic, facilitates diuresis, eliminating excess fluid and electrolytes while contributing to long-term vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Olwohn AT 40mg/5mg/12.5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Olwohn AT 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Olwohn AT 40mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olwohn AT 40mg/5mg/12.5mg Tablet side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olwohn AT 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. Olwohn AT 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Olwohn AT 40mg/5mg/12.5mg tablets. Dosage modification of Olwohn AT 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Olwohn AT 40mg/5mg/12.5mg Tablet :
Should you forget to take your Olwohn AT 40mg/5mg/12.5mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Olwohn AT 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
